OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Incidence of and risk factors for severe neutropenia during treatment with the modified FOLFIRINOX therapy in patients with advanced pancreatic cancer
Ai Irisawa, Misaki K Takeno, Kazuo Watanabe, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Ai Irisawa, Misaki K Takeno, Kazuo Watanabe, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity
Ritika Kurian, Hongbing Wang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 988-988
Open Access | Times Cited: 1
Ritika Kurian, Hongbing Wang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 988-988
Open Access | Times Cited: 1
HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis
Alpha Raj Mekapogu, Zhihong Xu, Srinivasa Pothula, et al.
Cancer Letters (2023) Vol. 568, pp. 216286-216286
Open Access | Times Cited: 11
Alpha Raj Mekapogu, Zhihong Xu, Srinivasa Pothula, et al.
Cancer Letters (2023) Vol. 568, pp. 216286-216286
Open Access | Times Cited: 11
The feasibility and potential benefits of administering adjuvant chemotherapy in resected pancreatic cancer patients unable to promptly remove intraperitoneal drainage post-surgery: A retrospective cohort study
Dong Xu, Nan Lv, Qianqian Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Dong Xu, Nan Lv, Qianqian Wang, et al.
Research Square (Research Square) (2025)
Closed Access
A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer
Suhaila O. Alhaj‐Suliman, Youssef W. Naguib, Emad I. Wafa, et al.
Biomaterials (2023) Vol. 296, pp. 122093-122093
Open Access | Times Cited: 10
Suhaila O. Alhaj‐Suliman, Youssef W. Naguib, Emad I. Wafa, et al.
Biomaterials (2023) Vol. 296, pp. 122093-122093
Open Access | Times Cited: 10
Incidence and non-genetic risk factors of irinotecan-induced severe neutropenia in Chinese adult inpatients
Zhang Shu-xiao, Jingxiang Yang, Haiyan Zhan, et al.
Medicine (2023) Vol. 102, Iss. 9, pp. e33005-e33005
Open Access | Times Cited: 2
Zhang Shu-xiao, Jingxiang Yang, Haiyan Zhan, et al.
Medicine (2023) Vol. 102, Iss. 9, pp. e33005-e33005
Open Access | Times Cited: 2
Systematic analysis of expression profiles and prognostic significance of the FGF gene family in pancreatic adenocarcinoma
Yuxin Chen, Xiaojuan Liu, Ling Yang, et al.
Oncology Letters (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 3
Yuxin Chen, Xiaojuan Liu, Ling Yang, et al.
Oncology Letters (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 3
Use of empegfilgrastim for primary prevention of febrile neutropenia in patients receiving myelosuppressive therapy. Experience of the Arkhangelsk Clinical Oncological Dispensary
Ya. S. Chapko, Д. М. Дубовиченко, A. A. Ruzhnikova, et al.
Podderživaûŝaâ terapiâ v onkologii. (2024) Vol. 1, Iss. 2, pp. 23-31
Closed Access
Ya. S. Chapko, Д. М. Дубовиченко, A. A. Ruzhnikova, et al.
Podderživaûŝaâ terapiâ v onkologii. (2024) Vol. 1, Iss. 2, pp. 23-31
Closed Access
Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948)
Mohamed Bouchahda, Ayhan Ulusakarya, Anne Thirot‐Bidault, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e069973-e069973
Open Access | Times Cited: 1
Mohamed Bouchahda, Ayhan Ulusakarya, Anne Thirot‐Bidault, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e069973-e069973
Open Access | Times Cited: 1
Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients
Willem de Koning, Casper W.F. van Eijck, Fleur van der Sijde, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4349-4349
Open Access | Times Cited: 1
Willem de Koning, Casper W.F. van Eijck, Fleur van der Sijde, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4349-4349
Open Access | Times Cited: 1
Exploration of Risk Factors in Severe Neutropenia Induced by Ramucirumab and Nab-paclitaxel Combination Therapy
S Oike, Yuki Kawarada, T. NAKAI, et al.
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) (2023) Vol. 49, Iss. 10, pp. 365-373
Closed Access
S Oike, Yuki Kawarada, T. NAKAI, et al.
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) (2023) Vol. 49, Iss. 10, pp. 365-373
Closed Access
